Alpha Cancer Technologies (ACT) Publishes Pre-Clinical Study Results in Cancer Cell International Demonstrating Excellent Safety and Significant Anti-Tumor Activity from the Company’s Next Generation ADC, ACT-903
Spoke,
TORONTO--(BUSINESS WIRE)-- Alpha Cancer Technologies Inc. (ACT), a biopharmaceutical company focused on developing and…